Early combined immunosuppression in Crohn's disease

Lancet. 2008 Jun 14;371(9629):1995; author reply 1996-7. doi: 10.1016/S0140-6736(08)60859-4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Azathioprine / administration & dosage
  • Azathioprine / therapeutic use*
  • Crohn Disease / drug therapy*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Remission Induction
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Azathioprine